|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/517 | |
| A61K 31/519 | |||
| A61P 35/00 | |||
| A61K 9/20 | |||
| A61K 9/48 |
| (11) | Patento numeris | 2571358 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11784240.1 |
| Europos patento paraiškos padavimo data | 2011-05-19 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-03-27 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-01-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2011/037146 |
| Data | 2011-05-19 |
| (87) | Numeris | WO 2011/146712 |
| Data | 2011-11-24 |
| (30) | Numeris | Data | Šalis |
| 374343 P | 2010-08-17 | US | |
| 347081 P | 2010-05-21 | US |
| (72) |
GILMER, Tona, M., US
KUMAR, Rakesh, US
|
| (73) |
GlaxoSmithKline LLC,
Corporation Service Company 2711 Centreville Road Suite 400, Wilmington, Delaware 19808,
US
|
| (54) | COMBINATION THERAPY FOR TREATING CANCER |
| COMBINATION THERAPY FOR TREATING CANCER |